Pioneers in Hyperinsulinism: Yesterday, Today and Tomorrow
Sep 18, 2018
CHOP’s groundbreaking expertise in treating children with congenital hyperinsulinism (HI) began more than 50 years ago and draws patients from all over the world.
Congenital Hyperinsulinism Center News
Our team of pediatric endocrinologists, surgeons, radiologists, pathologists, anesthesiologists, advanced practice nurses, nurses, social workers, genetic counselors, psychologists, researchers, speech and feeding therapists, and dietitians work together to provide specialized and seamless care.
Appointments
Referrals
Two Generations. Two Buildings. Always Expert Care: Parkes Family HI Story
Sep 10, 2018
Two generations of the Parkes family have come to Children’s Hospital of Philadelphia for treatment for hyperinsulinism (HI). They’ve seen and experienced breakthroughs in HI care firsthand.
CHOP’s Congenital Hyperinsulinism Center Celebrates 20 Years and 500 Surgeries
Oct 5, 2018
The center offers evaluation, diagnosis, treatment, and follow-up care for children with this life-threatening condition.
Diva D. De León-Crutchlow, MD, Named Chief of Endocrinology and Diabetes
Jun 25, 2018
Diva D. De León-Crutchlow, MD, MSCE, will assume the role as Chief of the Division of Endocrinology and Diabetes at Children’s Hospital of Philadelphia, effective July 1.
CHOP’s HI Team Leading Research Nationally
Mar 14, 2018
Our HI team has been busy continuing to pave the way to improve the diagnosis, treatment and outcomes for children with hyperinsulinism through discovery and innovation.
Dr. Stanley’s Pioneering Career Recognized
May 25, 2017
Charles A. Stanley, MD, received the Judson J. Van Wyk Prize, the most prestigious award given by the Pediatric Endocrine Society.
The Ups and Downs of Living with HI
May 25, 2017
Patients share their experiences of growing up with HI during the 2016 Congenital Hyperinsulinism Family Conference in Philadelphia.
Complex Biology of Hyperinsulinism May Offer Clues to Better Treatment
May 18, 2017
Studying cells from children born with hyperinsulinism, CHOP experts discover events at the cellular level that may lead to new treatments for this rare disease.